Physical State:White Powder
Synonyms:Acvr2b, Activin Receptor Type Iib
Usage:Bodybuilding ;Myostatin Blockers
ACE-031 is a soluble fusion protein that has been shown to increase muscle mass and strength in research studies. ACE-031 is being studied as a treatment for metabolic diseases, renal neoplasms of childhood, cardiovascular anomalies, age-related muscle loss, and cancer treatment related muscle loss and neuromuscular diseases. ACE-031 is a biologic therapeutic, based on activin receptor type IIB (ActRIIB). The molecule inhibits signaling via the ActRIIB receptor binding and increase muscle mass and strength. ACE-031 is a recombinant fusion protein that is artificially synthesized by fusion of standard antibody and a portion of ActRIIB receptor. The recombinant fusion protein eliminates myostatin and other biomolecules that limit muscle strength or growth.
Sportsmen taking 1 mg of ACE-031 once a week over the period of 3-4 weeks report nearly an immediate increase in the muscle hardness and the rapid growth of muscle mass and strength to an extent exceeding even the most efficient hardcore volume anabolic-androgenic steroid!
Another dosing option is to start with the dose of 200 mcg of ACE-031 per day and to increase the dose every week by 100 mcg, whereas the treatment cycle should last again 3-4 weeks.
Once a cycle with ACE-031 is completed, a break in the duration of two weeks is recommended.